| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/12/2010 | US7645771 HIV, acquired immune deficiency syndrome (AIDS); 1-(8-{2-[1-(2,2-Dimethylpropanoyl)-4-phenylpiperidin-4-yl]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-2-methyl-1H-benzimidazole |
| 01/12/2010 | US7645768 Production of polyketides and other natural products |
| 01/12/2010 | US7645570 Botulinum toxin screening assays |
| 01/12/2010 | CA2560489C Pyranone compounds useful to treat retroviral infections |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2466338C New uses for anti-malarial therapeutic agents |
| 01/12/2010 | CA2439831C Polymorphic and other crystalline forms of cis-ftc |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2403835C Anti-viral pyrimidine nucleoside analogues |
| 01/12/2010 | CA2402339C Viral antigen and vaccine against isav (infectious salmon anaemia virus) |
| 01/12/2010 | CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2331846C Expression vectors for stimulating an immune response and methods of using the same |
| 01/12/2010 | CA2287219C 2-oxo-1-azetidine sulfonic acid derivatives as potent .beta.-lactamase inhibitors |
| 01/12/2010 | CA2272845C Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 01/12/2010 | CA2170412C Modified plant viruses as vectors of heterologous peptides |
| 01/07/2010 | WO2010003053A2 Hsv-2 peptides for stimulation of cytotoxic t lymphocytes |
| 01/07/2010 | WO2010002998A1 2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS |
| 01/07/2010 | WO2010002415A1 Treatment of antibiotic-resistant bacteria infection |
| 01/07/2010 | WO2010002010A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001671A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 01/07/2010 | WO2010001509A1 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 01/07/2010 | WO2010001365A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/07/2010 | WO2010001267A2 Delivery product for topical compositions |
| 01/07/2010 | WO2010001220A1 New 1,2,4-triazine derivatives and biological applications thereof |
| 01/07/2010 | WO2010000704A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | WO2010000703A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | WO2010000686A2 Composition for topical use |
| 01/07/2010 | WO2010000668A1 A crystalline form of posaconazole |
| 01/07/2010 | WO2010000459A1 Cyclopropyl polymerase inhibitors |
| 01/07/2010 | WO2010000207A1 A natural allicin tablet and preparation method thereof |
| 01/07/2010 | WO2010000032A1 Compounds having antiviral properties |
| 01/07/2010 | WO2010000031A1 Imidazopyrimidinones and uses thereof |
| 01/07/2010 | WO2010000030A1 Thiazopyrimidinones and uses thereof |
| 01/07/2010 | WO2010000012A1 Method for preventing transport of a neurotropic virus |
| 01/07/2010 | WO2009143024A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/07/2010 | WO2009129336A3 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections |
| 01/07/2010 | WO2009088549A3 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 01/07/2010 | US20100004440 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/07/2010 | US20100004337 Electrostatically charged multi-acting nasal application, product, and method |
| 01/07/2010 | US20100004321 Recombinant Staphylococcal Phage Lysin as an Antibacterial Agent |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004282 Treatment of antibiotic-resistant bacteria infection |
| 01/07/2010 | US20100004281 Viral inhibitors |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004258 Novel Heterocyclic NF-kB Inhibitors |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004230 Azatricyclic compounds and their use |
| 01/07/2010 | US20100004207 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/07/2010 | US20100004205 Pharmaceutical compositions |
| 01/07/2010 | US20100004192 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| 01/07/2010 | US20100004187 Cobalt-amine based metal complex as an antibacterial compound |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100003330 Antimicrobial nanoemulsion compositions and methods |
| 01/07/2010 | US20100003296 Manufacturing methods and applications of antimicrobial plant fibers having silver particles |
| 01/07/2010 | US20100003287 Compositions and Methods Relating to Treatment of Cancer and Infectious Diseases |
| 01/07/2010 | US20100003285 Human Hookworm Vaccine |
| 01/07/2010 | US20100003284 Live attenuated aldolase-negative bacterial vaccine |
| 01/07/2010 | US20100003283 Lipid a deficient mutants of neisseria meningitidis |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003280 Adjuvant compositions |
| 01/07/2010 | US20100003279 Vaccine for in ovo inoculation |
| 01/07/2010 | US20100003278 Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof |
| 01/07/2010 | US20100003276 Methods for treating anthrax and inhibiting lethal factor |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003225 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| 01/07/2010 | US20100003221 Medium Supplement for Virus Production |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | US20100003214 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 01/07/2010 | US20100003213 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/07/2010 | CA2729818A1 Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides |
| 01/07/2010 | CA2729663A1 Compounds having antiviral properties |
| 01/07/2010 | CA2729656A1 Imidazopyrimidinones and uses thereof |
| 01/07/2010 | CA2729649A1 Thiazopyrimidinones and uses thereof |
| 01/07/2010 | CA2729617A1 A natural allicin tablet and preparation method thereof |
| 01/07/2010 | CA2729493A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | CA2729491A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2729404A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device |
| 01/07/2010 | CA2729316A1 Cyclopropyl polymerase inhibitors |
| 01/07/2010 | CA2729080A1 Cattle vaccines |
| 01/07/2010 | CA2728769A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/07/2010 | CA2728328A1 Treatment of antibiotic-resistant bacteria infection |
| 01/07/2010 | CA2728170A1 A crystalline form of posaconazole |
| 01/07/2010 | CA2633585A1 Treatments for any and all mental/brain neuron/spinal cord illness |
| 01/06/2010 | EP2141227A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 01/06/2010 | EP2141172A1 Cyclopropyl polymerase inhibitors |
| 01/06/2010 | EP2141171A1 Pyridine derivative substituted with heterocycle and phosphonoamino and antifungal agent containing the same |
| 01/06/2010 | EP2141164A1 New 1,2,4-triazine derivatives and biological applications thereof |
| 01/06/2010 | EP2141161A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/06/2010 | EP2141159A1 A Crystalline form of posaconazole |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP2140878A1 Vaccine against streptococcus pneumoniae |
| 01/06/2010 | EP2140877A1 New use of coccidian |